Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein á contributes to bladder cancer cell growth and reduced apoptosis

Oncology Reports

Volumn 31, Issue 5, 2014, Pages 1993-2000

  Xue, Mei ^a   Li, Xu ^a   Wu, Wenjing ^a   Zhang, Shuwan ^a   Wu, Shouzhen ^a   Li, Zhengkun ^a   Chen, Wei ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Bladder cancer; CCAAT enhancer binding protein ; Long non coding RNA; Transcription factor; Urothelial carcinoma associated 1

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA; UNTRANSLATED RNA UROTHELIAL CARCINOMA ASSOCIATED 1; BIOLOGICAL MARKER; LONG UNTRANSLATED RNA; PROTEIN BINDING; TUMOR MARKER; UCA1 RNA, HUMAN;

APOPTOSIS; ARTICLE; BINDING SITE; BLADDER CANCER; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; TRANSITIONAL CELL CARCINOMA; UPREGULATION; BIOSYNTHESIS; BLADDER TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENETIC TRANSCRIPTION; GENETICS; PATHOLOGY; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

APOPTOSIS; BINDING SITES; BIOLOGICAL MARKERS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; POINT MUTATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA INTERFERENCE; RNA, LONG NONCODING; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 84898636111     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3092     Document Type: Article

References (23)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63: 11-30, 2013
2. Jacobs BL, Lee CT and Montie JE: Bladder cancer in 2010: How far have we come? CA Cancer J Clin 60: 244-272, 2010
3. Kamat AM, Hegarty PK, Gee JR, et al: ICUD-EAU International Consultation on Bladder Sancer 2012: Screening, diagnosis, and molecular markers. Eur Urol 63: 4-15, 2013
4. Orom UA, Derrien T, Beringer M, et al: Long noncoding RNAs with enhancer-like function in human cells. Cell 143: 46-58, 2010
5. Guttman M, Donaghey J, Carey BW, et al: LincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477: 295-300, 2011
6. Lee JT: Epigenetic regulation by long noncoding RNAs. Science 338: 1435-1439, 2012
7. Taft RJ, Pang KC, Mercer TR, Dinger M and Mattick JS: Non-coding RNAs: Regulators of disease. J Pathol 220: 126-139, 2010
8. Gutschner T and Diederichs S: The hallmarks of cancer: A long non-coding RNA point of view. RNA Biol 9: 703-719, 2012
9. Wang XS, Zhang Z, Wang HC, et al: Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res 12: 4851-4858, 2006
10. Wang F, Li X, Xie X, Zhao L and Chen W: UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett 582: 1919-1927, 2008
11. Yang C, Li X, Wang Y, Zhao L and Chen W: Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene 496: 8-16, 2012
12. Wang Y, Chen W, Yang C, et al: Long non-coding RNA UCA1a (CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int J Oncol 41: 276-284, 2012
13. Chen G, Wang Z, Wang D, et al: LncRNADisease: A database for long-non-coding RNA-associated diseases. Nucleic Acids Res 41: D983-D986, 2013
14. Guttman M, Amit I, Garber M, et al: Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458: 223-227, 2009
15. Yang JH, Li JH, Jiang S, Zhou H and Qu LH: ChIPBase: A database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-Seq data. Nucleic Acids Res 41: D177-D187, 2013
16. Yang YC, Li X and Chen W: Characterization of genes associated with different phenotypes of human bladder cancer cells. Acta Biochim Biophys Sin 38: 602-610, 2006
17. Wu W, Zhang S, Li X, et al: Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells. PLoS One 8: E73920, 2013
18. Gupta RA, Shah N, Wang KC, et al: Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076, 2010
19. Brunner AL, Beck AH, Edris B, et al: Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol 13: R75, 2012
20. Panzitt K, Tschernatsch MM, Guelly C, et al: Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 132: 330-342, 2007
21. Wang J, Liu X, Wu H, et al: CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 38: 5366-5383, 2010
22. Huarte M, Guttman M, Feldser D, et al: A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142: 409-419, 2010
23. Wang M, Zhang Z, Zhu H, et al: A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population. Clin Cancer Res 14: 3633-3640, 2008